# Drug-Coated Balloon in Patients With High Bleeding Risk

> **NCT05221931** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 1359 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT05221931
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-29
- **Primary completion:** 2027-11
- **Final completion:** 2028-12
- **Target enrollment:** 1359 (ACTUAL)
- **Last updated:** 2026-02-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05221931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05221931, "Drug-Coated Balloon in Patients With High Bleeding Risk". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05221931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*